Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats

Psychopharmacology

Volumn 179, Issue 1, 2005, Pages 181-188

  O'Neill, Michael F ^a   Sanger, Graham ^a   Ornstein, Paul L ^a   Osborne, David J ^a   Woodhouse, Sandra M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

AMPA; ATPA; Decahydroisoquinoline; Kainic acid; Locomotor activity; Rat

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA AMINO 5 TERT BUTYL 3 HYDROXY 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR AGONIST; AMPA RECEPTOR ANTAGONIST; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 5; IONOTROPIC RECEPTOR AGONIST; IONOTROPIC RECEPTOR ANTAGONIST; ISOQUINOLINE DERIVATIVE; KAINIC ACID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR AGONIST; KAINIC ACID RECEPTOR ANTAGONIST; LY 302679; LY 377770; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BRAIN; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; ISOQUINOLINES; ISOXAZOLES; KAINIC ACID; MALE; MOTOR ACTIVITY; PROPIONATES; RATS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 17744372865     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2055-8     Document Type: Article

References (21)

1. Amt J, Sanchez C, Moltzen Lenz S, Madsen U, Krogsgaard-Larsen P (1995) Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity. Eur J Pharmacol 285:289-297
2. Benvenga MJ, Ornstein PL, Leander JD (1995) Schedule-controlled behavioral effects of the selective 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl- propanoic acid antagonist LY293558 in pigeons. J Pharmacol Exp Ther 275:164-170
3. Bleakman D, Schoepp D, Ballyk B, Bufton H, Sharpe EF, Thomas K, Ornstein PL, Kamboj RK (1996) Pharmacological discrimination of GluR5 and GluR6 kainate receptor subytpes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl] decahydydroisoquinoline-3 carboxylic acid. Mol Pharmacol 49:581-585
4. Burnashev N (1995) Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 25:987-990
5. Chittajallu R, Braithwaite SP, Clarke VRJ, Henley SJ (1999) Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol Sci 20:26-35
6. Clarke VRJ, Ballyk BA, Hoo KH, Mandelzys A, Pellizari A, Bat CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D (1997) A GluR5 kainate receptor that regulates inhibitory synaptic transmission in the hippocampus. Nature 389:599-603
7. Danysz W, Parsons C (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597-664
8. Danysz W, Essman U, Bresink I, Wilke R (1994) Glutamate antagonists have differential effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111-118
9. Dingledine R, Borge K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61
10. Lauridsen J, Honore T, Krogsgaard-Larsen P (1985) Ibotenic acids analogues synthesis, molecular flexibility and in vitro activity of agonists and antagonists at central glutamic acid receptors. J Med Chem 28:668-672
11. Maj J, Rogoz Z, Skuza G, Jaros T (1995) Some behavioral effects of CNQX and NBQX, AMPA receptor antagonists. Pol J Pharmacol 47:269-277
12. O'Neill MJ, Bond A, Ornstein PL, Ward MA, Hicks CA, Hoo K, Bleakman D, Lodge D (1998) Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischemia. Neuropharmacology 37: 1211-1222
13. O'Neill MJ, Bogaert L, Hicks CA, Bond A, Ward MA, Ebinger G, Ornstein PL, Michotte Y, Lodge D (2000) LY3 77770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal ischemia. Neuropharmacology 39:1575-1588
14. Ornstein PL, Arnold, MB, Augenstein NK, Lodge D, Leander JD, Schoepp DD (1993) (3SR, 4aRS, 6RS, 8aRS)-6-(2-(1H-Tetrazol-5-yl)ethyl-] decahydroisoquinoline-3-carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist. J Med Chem 36:2046-2048
15. Ornstein PL, Arnold MB, Allen NK, Bleisch T, Borromeo PS, Lugar CW, Leander JD, Lodge D, Schoepp DD (1996) Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid biosteric substitution, absolute stereochemical preferences, and in vivo activity. J Med Chem 39:2232-2244
16. Otis T, Zhang S, Trussell LO (1996) Direct measurement of AMPA receptor desensitization induced by glutamatergic synaptic transmission. J Neurosci 16:7496-7504
17. Royle SJ, Collins FC, Rupniak HT, Barnes JC, Anderson R (1999) Behavioural analysis and susceptibility to CNS injury of four inbred strains of mice. Brain Res 816:337-349
18. Schoepp DD, Gamble AY, Salhoff CR, Johnson BG, Ornstein PL (1990) Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. Eur J Pharmacol 182:421-427
19. Seeburg PH (1993) The molecular biology of mammalian glutamate receptor channels. Trends Pharmacol Sci 14:297-303
20. Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10:1301-1315
21. Wilding TJ, Huettner JE (1996) Antagonist pharmacology of kainate-and alpha-amino-3-hydroxy-5-methyl-isoxazolepropionic acid-preferring receptors. Mol Pharmacol 49:540-546